What's Happening?
The CPHI & PMEC China 2026, Asia's largest pharmaceutical show, is set to take place from June 16 to 18 at the Shanghai New International Expo Centre. The event will host over 110,000 attendees and more than 3,600 exhibitors, making it a premier destination
for pharmaceutical ingredients and manufacturing solutions. The show will feature over 100 conferences and workshops led by 700 experts, providing insights into market intelligence and technical expertise. This year's edition aims to showcase China's advancements in pharmaceutical innovation, including traditional Chinese medicine and next-generation API development.
Why It's Important?
The return of CPHI & PMEC China underscores China's pivotal role in the global pharmaceutical industry. As a hub for pharmaceutical ingredients and manufacturing, China's advancements in this sector have significant implications for global health and medicine. The event provides a platform for international companies to engage with Chinese manufacturers, fostering partnerships and innovation. For the U.S., this highlights the importance of maintaining strong trade relations with China, particularly in the pharmaceutical sector, which is crucial for drug development and supply chain stability.
